Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06597292 · ClinicalTrials.gov registry record · NA
The VIS Opti-K Low Vision Aid Device Provides Vision Improvement.
A NA study, sponsored by VIS.
- Not yet
- Registry status
- NA
- Development phase
- 200
- Enrollment target
NCT06597292: Clinical Trial NA study, sponsored by VIS.
NCT06597292 is a NA study that has not yet begun recruiting, run by VIS. The registered enrollment target is 200 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06597292, a NA study, has not yet begun recruiting, sponsored by VIS.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
Study Summary
The VIS Opti-K Low Vision Aid device will be used to provide vision improvement to patients with refractive disorders (hyperopia and presbyopia).
Primary Outcome
Uncorrected distance visual acuity (UDVA) is to be measured and reported using standard ETDRS visual acuity charts. UDVA change from baseline is also to be reported.
Interventions
- DEVICE Vision improvement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2024-09-16 |
| Est. Completion | 2026-12-30 |
| Phase | NA |
What is known before NCT06597292 opens enrollment
NCT06597292 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 1 intervention - of which Vision improvement is the first listed.
NCT06597292 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06597292 about?
NCT06597292 is a clinical study titled "The VIS Opti-K Low Vision Aid Device Provides Vision Improvement.". The VIS Opti-K Low Vision Aid device will be used to provide vision improvement to patients with refractive disorders (hyperopia and presbyopia).
What is the current status of trial NCT06597292?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2024-09-16. Estimated completion is 2026-12-30.
What interventions are being tested in trial NCT06597292?
The interventions under investigation include: Vision improvement (DEVICE).
Who is sponsoring clinical trial NCT06597292?
This trial is sponsored by VIS, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06597292's enrollment target sits among peer trials
200 506th of 2000 higher than 1,434 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI